ReviewMolecules (Basel, Switzerland)2022
Literature Mining of Disease Associated Noncoding RNA in the Omics Era.
Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Large Language Models for Non-Coding RNA Biomarker Discovery in Breast Cancer.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia.International journal of molecular sciences · 2025Review
- Editorial: Non-coding RNAs in heart failure.Frontiers in cardiovascular medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noncoding RNAs (ncRNA) are transcripts without protein-coding potential that play fundamental regulatory roles in diverse cellular processes and diseases. The application of deep sequencing experiments in ncRNA research have generated massive omics datasets, which require rapid examination, interpretation and validation based on exiting knowledge resources. Thus, text-mining methods have been increasingly adapted for automatic extraction of relations between an ncRNA and its target or a disease condition from biomedical literature. These bioinformatics tools can also assist in more complex research, such as database curation of candidate ncRNAs and hypothesis generation with respect to pathophysiological mechanisms. In this concise review, we first introduced basic concepts and workflow of literature mining systems. Then, we compared available bioinformatics tools tailored for ncRNA studies, including the tasks, applicability, and limitations. Their powerful utilities and flexibility are demonstrated by examples in a variety of diseases, such as Alzheimer's disease, atherosclerosis and cancers. Finally, we outlined several challenges from the viewpoints of both system developers and end users. We concluded that the application of text-mining techniques will booster disease-associated ncRNA discoveries in the biomedical literature and enable integrative biology in the current omics era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.